Analysts Set $2.81 Target Price for Agilon Health Shares

Shares of Agilon Health, Inc. (NYSE:AGL) have received an average rating of “Hold” from analysts covering the company, according to a report from MarketBeat.com. The consensus target price stands at approximately $2.81 for the next year, reflecting a cautious outlook from financial experts.

Out of nineteen ratings firms, two analysts recommend selling the stock, while thirteen suggest holding it, and four have given it a buy rating. Recent reports have highlighted a range of target price adjustments for Agilon Health, indicative of the stock’s current volatility.

Recent Analyst Ratings and Adjustments

In a notable shift, Benchmark recently lowered its price target for Agilon Health from $4.00 to $1.50, maintaining a buy recommendation. This adjustment came in a report dated August 6, 2023.

Similarly, Barclays reduced its price target from $3.00 to $1.50, adopting an “underweight” rating in their research note also released on August 6. On October 7, Wells Fargo & Company cut its target price from $5.00 to $1.50, but retained an “overweight” rating for the company.

In a contrasting move, Zacks Research upgraded Agilon Health from a “strong sell” to a “hold” rating on October 10, reflecting some level of optimism amidst the broader concerns.

Financial Performance and Market Position

Agilon Health’s stock opened at $0.98 on October 10, 2023. The company has experienced fluctuations over the past year, with a twelve-month low of $0.71 and a high of $6.08. Currently, Agilon Health has a market capitalization of $407.79 million, a price-to-earnings ratio of -1.28, and a beta of 0.07.

The company recently reported its quarterly earnings on August 4, 2023. Agilon Health posted an earnings per share (EPS) of ($0.25), falling short of the consensus estimate of ($0.11) by $0.14. The firm’s revenue for the quarter was $1.39 billion, below analysts’ expectations of $1.47 billion, marking a 5.9% decline year-over-year.

Analysts currently anticipate Agilon Health will report an EPS of ($0.59) for the current fiscal year, indicating ongoing challenges as the company navigates its market landscape.

Agilon Health, Inc. specializes in providing healthcare services for seniors through primary care physicians across the United States. The company operates on a subscription-like model, managing the total healthcare needs of patients on a per-member per-month basis. Previously known as Agilon Health Topco, Inc., the company rebranded to Agilon Health, Inc. as part of its strategic initiatives to enhance market presence and operational effectiveness.

As the healthcare landscape evolves, investors and analysts will continue to monitor Agilon Health’s performance and strategic decisions closely, particularly in light of recent ratings adjustments and financial results.